Laboratory Story

All StoriesRisk
Gabriel Shpitalnik Story
<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;'>LC</div>
LH -- USA Stock  

USD 239.91  3.38  1.43%

Macroaxis News
By Gabriel Shpitalnik  
Macroaxis Story
It seems as Laboratory will continue to recover much faster as its share price surged up 1.07% today. Laboratory Of Ameri current daily volatility is 1.55 percent, with a beta of -0.11 and an alpha of 0.13 over DOW. As many investors are getting excited about healthcare, it is fair to concentrate on Laboratory. We will evaluate if Laboratory shares are reasonably priced going into March.
Published over two weeks ago
View all stories for Laboratory Corp | View All Stories
Should we continue shadow Laboratory (NYSE:LH) executives?
Laboratory reports roughly 667.2 M in cash with 1.93 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.85. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Laboratory has an asset utilization ratio of 482.1 percent. This implies that the company is making $4.82 for each dollar of assets. An increasing asset utilization means that Laboratory is more efficient with each dollar of assets it utilizes for everyday operations.
Investing in Laboratory Corp, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Laboratory Corp along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Laboratory Corp's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Laboratory Corp in the context of predictive analytics.
Hype
Prediction
Details
Intrinsic
Valuation
Details
14 Analysts
Consensus
Details
Earnings
Estimates (9)
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Laboratory Corp. Your research has to be compared to or analyzed against Laboratory Corp's peers to derive any actionable benefits. When done correctly, Laboratory Corp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Laboratory Corp.

How important is Laboratory Corp's Liquidity

Laboratory Corp financial leverage refers to using borrowed capital as a funding source to finance Laboratory Corp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Laboratory Corp financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Laboratory Corp's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Laboratory Corp, but it might be worth checking our own buy vs. sell analysis

Laboratory Corp Correlation with Peers

Investors in Laboratory can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Laboratory Corp. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Laboratory Corp and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Laboratory is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Laboratory for more details

Exercise or conversion by Peter Wilkinson of 633 shares of Laboratory Corp subject to Rule 16b-3

Legal trades by Laboratory Corp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Laboratory insider trading alert for exercise of non-qualified stock options by Peter Wilkinson, SVP Chief Accounting Officer, on 19th of February 2021. This event was filed by Laboratory Corp Of Americ with SEC on 2021-02-19. Statement of changes in beneficial ownership - SEC Form 4. Peter Wilkinson currently serves as senior vice president, chief accounting officer of Laboratory Corp [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper Perspective

Laboratory appears to be very steady, given 1 month investment horizon. Laboratory Of Ameri has Sharpe Ratio of 0.15, which conveys that the firm had 0.15% of return per unit of risk over the last month. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Laboratory, which you can use to evaluate future volatility of the firm. Please exercise Laboratory Mean Deviation of 1.28, downside deviation of 1.89, and Risk Adjusted Performance of 0.0641 to check out if our risk estimates are consistent with your expectations.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Will Laboratory continue to rise?

Current jensen alpha is at 0.13. Laboratory has relatively low volatility with skewness of -0.87 and kurtosis of 3.54. However, we advise all investors to independently investigate Laboratory to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.

Our Bottom Line On Laboratory Of Ameri

While some other entities within the diagnostics & research industry are still a little expensive, even after the recent corrections, Laboratory may offer a potential longer-term growth to stockholders. To conclude, as of the 11th of February 2021, we believe that at this point, Laboratory is overvalued with very low chance of distress within the next 2 years. Our final buy-hold-sell recommendation on the company is Cautious Hold.

About Contributor

Gabriel Shpitalnik is a Member of Macroaxs Editorial Board. Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Laboratory Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
Macroaxis Wealth Optimization Platform
 
Feedback Blog
Made with optimal in San Francisco
2021 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY